XL092
XL092 (JUN04542) is a small molecule inhibitor targeting Axl, Mer, and c-Met receptor tyrosine kinases. It is a research tool for studying cancers dependent on these pathways and has demonstrated activity in preclinical in vitro and in vivo models of tumor growth and metastasis.
Product Specifications
CAS Number
2367004-54-2
Product Name Alternative
CL092, CL-092, CL 092, cMet/HGFR, c-Met/HGFR, cMet, c-Met, Axl, ATP, inhibit, KDR, JUN04542, JUN-04542, JUN 04542, orally, p-MET, Inhibitor, HGFR, Mer, TAM Receptor, TAMReceptor, p-VEGFR2, XL 092, XL-092, XL092, Tyro3, Vascular endothelial growth factor receptor, VEGFR
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.60% (May vary between batches)
Solubility
DMSO:5.29 mg/mL (10.01 mM)
Smiles
CNC (=O) c1cc2c (Oc3ccc (NC (=O) C4 (CC4) C (=O) Nc4ccc (F) cc4) cc3) ccnc2cc1OC
Molecular Formula
C29H25FN4O5
Molecular Weight
528.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
330249-01 50 µg
POTE-8 (POTE Ankyrin Domain Family Member A, ANKRD26-like Family A Member 1, Prostate, Ovary, Testis-expressed Protein on Chromosome 8, POTE-8, POTEA, A26A1, POTE8) discontinued
Sign In for Pricing
View Details